About Cellebration Life Sciences
Cellebration Life Sciences is a private company based in Phoenix, Arizona, incorporated in 2020 in Wyoming. It has reported $2,804,527 raised in one offering on Form D since June 2021. Its chief executive is Tim Kopatich.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 18, 2021 | Jun 2, 2021amended Aug 21, 2023 | $2,804,527of $20.0M target | 63 | $44,516 | EquityRule 506(c) | Form D/A ↗3 earlier filings |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cellebration Life Sciences's Form D filed Aug 21, 2023.